Nasdaq

Roche to launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in countries accepting the CE Mark to enable rapid differentiation of viral respiratory infections

Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...
Business Wire

Siemens Healthineers Announces FDA Emergency Use Authorization For CLINITEST® Rapid COVID-19 Antigen Self-Test

The CLINITEST Rapid COVID-19 Antigen Self-Test has received FDA EUA for unsupervised self-testing for the SARS-CoV-2 virus by individuals age 14 and older (or adult-collected samples from individuals ...
CNN

GenMark Receives FDA Emergency Use Authorization for its ePlex® SARS-CoV-2 Test

CARLSBAD, Calif., March 19, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the ...
BioWorld

Roche gains US EUA for SARS-CoV-2, influenza, RSV molecular test

The granting of emergency use authorization by the U.S. FDA to Roche AG for its four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and respiratory syncytial virus will allow the company ...
Business Wire

ActivePure’s Advanced Photohydrolysis Technology Demonstrates Rapid Inactivation of SARS-CoV-2, RSV, and Monkeypox Virus in Aerosolized Form

A New Study conducted in partnership with The University of Texas Medical Branch (UTMB) and Published in the American Journal of Infection Control (AJIC) Shows Significant Reduction of Airborne ...